ORPHA:2248
Hypoplastic left heart syndrome
Also known as: HLHS
Publications
10,950
Trials
36
Interventional, condition-specific
Researchers
1,269
Distinct authors in sample
Gene link
DENND5B
Limited
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare, , non-syndromic, heart characterized by under development of the left-sided cardiac structures (including left ventricle, ascending aorta, aortic arch, and mitral and/or aortic valve) such that the left heart is unable to provide adequate systemic cardiac output.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0004933
- MeSH:D018636
- UMLS:C0152101
- NCIT:C98894
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Limited — DENND5B
- LiteraturePresent
10,950 matched papers (6,285 in last 10 years) Source
- Phenotype characterisedPresent
14 HPO annotations (e.g. Hypoplastic left ventricle; Aortic valve stenosis; Coarctation of aorta) Source
- Animal modelPresent
15 genotype models (Danio rerio, Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
36 matched on ClinicalTrials.gov (5 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Possibly — only limited evidence so far for DENND5B.
GenCC classification: Limited.
Phenotypes (Monarch / HPO)
14
Associated phenotypes · MONDO:0004933
- Hypoplastic left ventricle
- Aortic valve stenosis
- Coarctation of aorta
- Mitral atresia
Showing 4 of 14 — open Monarch for the full list.
Animal models (Monarch / Alliance)
15
Model associations linked to this Mondo ID
- AB + MO2-sap130a·ZFIN:ZDB-FISH-170815-9·Danio rerio
- sap130apt32a/pt32a·ZFIN:ZDB-FISH-170815-8·Danio rerio
- b2b3077.2Clo/b2b3077.2Clo [background:] C57BL/6J-b2b3077.2Clo·MGI:5648030·Mus musculus
- Pcdha9em1Clo/Pcdha9em1Clo Sap130em1Clo/Sap130em1Clo [background:] C57BL/6J-Sap130em1Clo Pcdha9em1Clo/MurrJ·MGI:5907019·Mus musculus
- b2b635Clo/b2b635Clo [background:] C57BL/6J-b2b635Clo·MGI:5312337·Mus musculus
- b2b1709Clo/b2b1709Clo [background:] C57BL/6J-b2b1709Clo·MGI:5445972·Mus musculus
- b2b3077Clo/b2b3077Clo [background:] C57BL/6J-b2b3077Clo·MGI:5648026·Mus musculus
- Nkx2-5tm3.1Mwc/Nkx2-5+ [background:] B6J.Cg-Nkx2-5tm3.1Mwc/Mwc·MGI:5882084·Mus musculus
- b2b1963Clo/b2b1963Clo [background:] C57BL/6J-b2b1963Clo·MGI:5467392·Mus musculus
- Nkx2-5tm2.1Mwc/Nkx2-5+ [background:] B6J.Cg-Nkx2-5tm2.1Mwc/Mwc·MGI:5829832·Mus musculus
- Sap130b2b635.2Clo/Sap130b2b635.2Clo [background:] C57BL/6J-Sap130b2b635.2Clo Pcdha9b2b635.1Clo·MGI:5906294·Mus musculus
- b2b1432Clo/b2b1432Clo [background:] C57BL/6J-b2b1432Clo·MGI:5445971·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
3
Drugs / clinical candidates · MONDO_0004933
- PHENOXYBENZAMINE·phase 2
- AUTOLOGOUS CORD BLOOD·phase 1 2
- OXANDROLONE·phase 1 2
CTD chemicals (MyDisease.info)
5 associated chemicals · 21 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- pifithrin · therapeutic
- 3,4,5,3',4'-pentachlorobiphenyl · marker/mechanism
- Nitrofurantoin · marker/mechanism
- Sulfonamides · marker/mechanism
- Valproic Acid · marker/mechanism
Pathways: Protein processing in endoplasmic reticulum; Apoptosis; Focal adhesion; Alzheimer's disease; Degradation of the extracellular matrix; Extracellular matrix organization; Disease; YAP1- and WWTR1 (TAZ)-stimulated gene expression
Literature
Is anyone studying this?
10,950
10,950 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
10,950 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
6,285 in the last 10 years · low confidence
Phrase hits: 10,746 · MeSH hits: 0
Who's working on it?
1,269
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Ewert P7 papers · 2026
Clinic of Congenital Heart Disease and Pediatric Cardiology, German Heart Center, TUM University Hospital, Technical University of Munich, Munich, 80636, Germany.
Papers in Europe PMC - 02Hörer J7 papers · 2026
Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 03Hager A6 papers · 2026
Department of Congenital Heart Disease and Pediatric Cardiology, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 04Ono M6 papers · 2026
Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 05Heinisch PP5 papers · 2026
Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 06Kalfa D5 papers · 2026
Section of Pediatric and Congenital Cardiac Surgery, Morgan Stanley Children's Hospital/Columbia University Irving Medical Center, New York, NY.
Papers in Europe PMC - 07Matsubara M5 papers · 2026
Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 08Palm J5 papers · 2026
Department of Congenital Heart Disease and Pediatric Cardiology, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 09Piber N5 papers · 2026
Department of Cardiovascular Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC - 10Schaeffer T5 papers · 2026
Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Center, Munich, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
36
interventional trials for this specific condition
36 interventional trials matched this specific condition name; 5 currently recruiting in our sample.
Data as of 11 September 2026 · last trial check 28 July 2026
36 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 96.4th percentile).
low confidence · 96.4th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
36 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06461676·NOT YET RECRUITING·Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)
Not reviewed·Conditions: Hypoplastic Left Heart Syndrome·Matched via name phrase
- NCT06342999·ENROLLING BY INVITATION·Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
Not reviewed·Conditions: Hypoplastic Left Heart Syndrome·Matched via name phrase
- NCT06853054·NOT YET RECRUITING·Seeking for Perfected Aortic Arch Reconstruction Using a Graphically Designed Patient-specific Surgical Patch
Not reviewed·Conditions: Hypoplastic Left Heart Syndrome (HLHS) · Aortic Arch Hypoplasia·Matched via name phrase
- NCT02781922·RECRUITING·Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
Not reviewed·Conditions: Hypoplastic Left Heart Syndrome · Single Ventricle·Matched via name phrase
- NCT04467671·RECRUITING·Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Not reviewed·Conditions: HLH - Hypoplastic Left Heart Syndrome · DORV · DILV - Double Inlet Left Ventricle · Mitral Atresia·Matched via name phrase
Observational and natural-history studies
21 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05386173·RECRUITING·Effect of Fetal Aortic Valvuloplasty on Outcomes
Not reviewed·Conditions: Congenital Heart Disease · Aortic Valve Stenosis · Fetal Cardiac Disorder · Hypoplastic Left Heart Syndrome·Matched via name phrase
- NCT02852031·RECRUITING·National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Not reviewed·Conditions: Hypoplastic Left Heart Syndrome (HLHS)·Matched via name phrase
- NCT06768008·RECRUITING·An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Not reviewed·Conditions: Congenital Heart Disease · Coarctation of Aorta · Aortic Stenosis · Pulmonary Atresia·Matched via name phrase
- NCT06711666·RECRUITING·Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
Not reviewed·Conditions: Congenital Heart Disease · Cyanotic Congenital Heart Disease · d-Transposition of the Great Arteries · Hypoplastic Left Heart Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (1)
- ctis·2024-512679-11-00·Authorised, ongoing·Prospective, randomized, controlled, open, multicenter clinical trial on the efficacy and safety of materno-fetal hyperoxygenation (MFHO) during the third trimester of pregnancy to treat underdeveloped left ventricular structures of the fetus
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Hypoplastic left heart syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Hypoplastic left heart syndrome") OR ("DENND5B" OR "DENND5B syndrome" OR "DENND5B-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Hypoplastic left heart syndrome"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 36 interventional · 21 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: HLHS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (10950) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T19:34:37.958Z
